Covalent Conjugation of Antibodies to Gold Nanoparticles Tutorial

Added:

Oriented (Site-Specific) Conjugation

While standard covalent conjugation to carboxyl-functionalized gold nanoparticles (typically using EDC/NHS chemistry) offers excellent stability, it suffers from a major limitation: random orientation. Because carboxyl groups couple indiscriminately to any accessible primary amines (such as lysine residues) on the antibody, many antibodies are immobilized with their antigen-binding sites (CDRs) sterically hindered or facing inward. This can significantly reduce the functional sensitivity of the lateral flow assay. An alternative, critical perspective advocates for oriented (site-specific) conjugation. This methodology utilizes adapter proteins (such as Protein A, G, or streptavidin) or site-specific chemistry (such as targeting carbohydrate moieties on the antibody's Fc region) to ensure that the antigen-binding domains remain fully exposed. Proponents of oriented conjugation argue that it achieves superior antigen-binding efficiency, lower limits of detection, and greater reproducibility compared to standard random covalent coupling, which often wastes valuable antibodies by rendering them inactive.

Understanding of antibody structure and function, particularly the location and role of primary amine groups (-NH2) on the protein structure.
Basic knowledge of nanotechnology and colloidal gold properties, including the significance of surface chemistry and nanoparticle stability.
Familiarity with bioconjugation chemistry principles, specifically carbodiimide coupling (EDC/NHS reaction) used to link carboxyl groups to amines.
The fundamental principles of Lateral Flow Assays (LFAs), including how target analytes, capture antibodies, and reporter particles interact on a strip.
Methods for characterizing conjugated gold nanoparticles, such as UV-Vis spectroscopy, Dynamic Light Scattering (DLS), and Zeta potential measurements to verify size and charge.
Optimization strategies for lateral flow assays, including the selection of blocking agents (e.g., BSA, PEG) to eliminate non-specific binding and reduce background signal.
Advanced site-directed conjugation chemistries, such as using linker molecules or targeting carbohydrate chains, to ensure optimal antibody orientation.
Troubleshooting and scaling up the manufacturing of diagnostic test strips, including assay sensitivity, shelf-life stability, and reproducibility.
16.8K views209likes4:42@nanocomposixOriginal Release: 2017-01-17

This video demonstrates a step-by-step protocol for covalently conjugating antibodies to carboxyl gold nanoparticles using EDC and Sulfo-NHS crosslinkers. The process involves activating the nanoparticle surface with EDC (10 mg/mL) and Sulfo-NHS (16 μL/mL for 1 mL gold nanoshells), incubating with antibody (20 μg/mL), quenching remaining reactive groups with hydroxylamine, and purifying the conjugate by centrifugation. This covalent conjugation method enables rapid antibody screening for lateral flow assay development, reducing optimization time from days/weeks to hours compared to passive conjugation methods.